Literature DB >> 21686775

Identification of a novel PEX14 mutation in Zellweger syndrome.

Sofie J Huybrechts1, Paul P Van Veldhoven, Ilse Hoffman, Renate Zeevaert, Rita de Vos, Philippe Demaerel, Marijke Brams, Jaak Jaeken, Marc Fransen, David Cassiman.   

Abstract

Here we report a patient with Zellweger syndrome, who presented at the age of 3 months with icterus, dystrophy, axial hypotonia, and hepatomegaly. Abnormal findings of metabolic screening tests included hyperbilirubinaemia, hypoketotic dicarboxylic aciduria, increased C(26:0) and decreased C(22:0) plasma levels, and strongly reduced plasmalogen concentrations. In fibroblasts, both peroxisomal α- and β-oxidation were impaired. Liver histology revealed bile duct paucity, cholestasis, arterial hyperplasia, very small branches of the vena portae, and parenchymatic destruction. Immunocytochemical analysis of cultured fibroblasts demonstrated that the cells contain peroxisomal remnants lacking apparent matrix protein content and PEX14, a central membrane component of the peroxisomal matrix protein import machinery. Transfection of fibroblasts with a plasmid coding for wild-type PEX14 restored peroxisomal matrix protein import. Mutational analysis of this gene revealed a genomic deletion leading to the deletion of exon 3 from the coding DNA (c.85-?_170+?del) and a concomitant change of the reading frame (p.[Ile29_Lys56del;Gly57GlyfsX2]).

Entities:  

Year:  2009        PMID: 21686775      PMCID: PMC3027610          DOI: 10.1136/bcr.07.2008.0503

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  29 in total

1.  Identification, purification and characterization of an acetoacetyl-CoA thiolase from rat liver peroxisomes.

Authors:  V D Antonenkov; K Croes; E Waelkens; P P Van Veldhoven; G P Mannaerts
Journal:  Eur J Biochem       Date:  2000-05

2.  Functional studies on human Pex7p: subcellular localization and interaction with proteins containing a peroxisome-targeting signal type 2 and other peroxins.

Authors:  Karen Ghys; Marc Fransen; Guy P Mannaerts; Paul P Van Veldhoven
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

3.  Newly identified Chinese hamster ovary cell mutants defective in peroxisome biogenesis represent two novel complementation groups in mammals.

Authors:  K Tateishi; K Okumoto; N Shimozawa; T Tsukamoto; T Osumi; Y Suzuki; N Kondo; I Okano; Y Fujiki
Journal:  Eur J Cell Biol       Date:  1997-08       Impact factor: 4.492

Review 4.  Peroxisomal disorders: the single peroxisomal enzyme deficiencies.

Authors:  Ronald J A Wanders; Hans R Waterham
Journal:  Biochim Biophys Acta       Date:  2006-08-23

5.  Identification of peroxisomal proteins by using M13 phage protein VI phage display: molecular evidence that mammalian peroxisomes contain a 2,4-dienoyl-CoA reductase.

Authors:  M Fransen; P P Van Veldhoven; S Subramani
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

6.  Functional domains and dynamic assembly of the peroxin Pex14p, the entry site of matrix proteins.

Authors:  Ryota Itoh; Yukio Fujiki
Journal:  J Biol Chem       Date:  2006-02-02       Impact factor: 5.157

7.  Recombinant human peroxisomal targeting signal receptor PEX5. Structural basis for interaction of PEX5 with PEX14.

Authors:  W Schliebs; J Saidowsky; B Agianian; G Dodt; F W Herberg; W H Kunau
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

8.  Identification of a new complementation group of the peroxisome biogenesis disorders and PEX14 as the mutated gene.

Authors:  Nobuyuki Shimozawa; Toshiro Tsukamoto; Tomoko Nagase; Yasuhiko Takemoto; Naoki Koyama; Yasuyuki Suzuki; Masayuki Komori; Takashi Osumi; Gootjes Jeannette; Ronald J A Wanders; Naomi Kondo
Journal:  Hum Mutat       Date:  2004-06       Impact factor: 4.878

9.  Oral bile acid treatment and the patient with Zellweger syndrome.

Authors:  K D Setchell; P Bragetti; L Zimmer-Nechemias; C Daugherty; M A Pelli; R Vaccaro; G Gentili; E Distrutti; G Dozzini; A Morelli
Journal:  Hepatology       Date:  1992-02       Impact factor: 17.425

10.  Aminotriazole is a potent inhibitor of alpha-oxidation of 3-methyl-substituted fatty acids in rat liver.

Authors:  M Casteels; K Croes; P P Van Veldhoven; G P Mannaerts
Journal:  Biochem Pharmacol       Date:  1994-11-16       Impact factor: 5.858

View more
  1 in total

1.  A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma.

Authors:  Alberto Galvez-Ruiz; Alicia Galindo-Ferreiro; Hind Alkatan
Journal:  Saudi J Ophthalmol       Date:  2017-09-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.